Ingevity (NYSE: NGVT) is one of 33 publicly-traded companies in the “Commodity Chemicals” industry, but how does it compare to its rivals? We will compare Ingevity to related businesses based on the strength of its institutional ownership, analyst recommendations, profitability, dividends, valuation, risk and earnings.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Ingevity and its rivals, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ingevity 0 0 5 0 3.00
Ingevity Competitors 108 840 1237 36 2.54

Ingevity currently has a consensus price target of $79.20, indicating a potential upside of 12.24%. As a group, “Commodity Chemicals” companies have a potential downside of 4.19%. Given Ingevity’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Ingevity is more favorable than its rivals.

Volatility & Risk

Ingevity has a beta of 1.78, meaning that its stock price is 78% more volatile than the S&P 500. Comparatively, Ingevity’s rivals have a beta of 1.13, meaning that their average stock price is 13% more volatile than the S&P 500.

Profitability

This table compares Ingevity and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ingevity 9.86% 58.14% 12.09%
Ingevity Competitors -29.50% 24.34% 5.63%

Earnings and Valuation

This table compares Ingevity and its rivals gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Ingevity $908.30 million $35.20 million 31.78
Ingevity Competitors $4.01 billion $340.26 million 157.76

Ingevity’s rivals have higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Insider & Institutional Ownership

91.4% of Ingevity shares are owned by institutional investors. Comparatively, 70.9% of shares of all “Commodity Chemicals” companies are owned by institutional investors. 0.1% of Ingevity shares are owned by company insiders. Comparatively, 7.8% of shares of all “Commodity Chemicals” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Ingevity beats its rivals on 8 of the 13 factors compared.

About Ingevity

Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals. The Performance Materials segment primarily produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Performance Chemicals segment develops, manufactures and sells a range of specialty chemicals primarily derived from co-products of the Kraft pulping process. Its products are used in a range of applications, including asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, publication inks and automotive components that reduce gasoline vapor emissions.

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.